Not cancer · Austria
Coronary artery disease
How is it diagnosed today? Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. MedlinePlus
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.26 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Lifestyle changes and medicines; stents or bypass if needed. NHS
15 medicines are approved for this disease in Austria:
Show all 15
- Cangrelor (Kengrexal) – approved in 2015
- Clopidogrel (Clopidogrel Zentiva, Plavix, Clopidogrel Viatris) – approved in 1998
- Clopidogrel and acetylsalicylic acid (DuoPlavin, Clopidogrel / Acetylsalicylic acid Viatris, Clopidogrel/Acetylsalicylic acid Zentiva) – approved in 2010
- Colchicine (Colchicine Agepha Pharma, Colctab) – approved in 2026
- Enoxaparin (Inhixa, Lovenox, Enoxaparin sodium) – approved in 2016
- Eptifibatide (Eptifibatide Accord, Eptifibatide) – approved in 2016
- Evolocumab (Repatha) – approved in 2015
- Fondaparinux (Arixtra) – approved in 2002
- Ivabradine (Ivabradine Anpharm, Corlentor, Procoralan) – approved in 2005
- Prasugrel (Prasugrel Viatris, Efient, Effient) – approved in 2009
- Ranolazine (Ranexa, Aspruzyo Sprinkle) – approved in 2008
- Rivaroxaban (Rivaroxaban Viatris, Xarelto, Rivaroxaban Accord) – approved in 2008
- Telmisartan (Micardis, Tolura, Telmisartan Actavis) – approved in 1998
- Tenecteplase (Metalyse, TNKase) – approved in 2001
- Ticagrelor (Brilique, Brilinta, Ticagrelor Zydus) – approved in 2010
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (56)
- Acebutolol (Sectral, Acebutolol Teva) – approved for it in France
- Acenocoumarol (Sintrom) – approved for it in France
- Acetylsalicylic acid (Aspirin Cardio) – approved for it in Switzerland
- Alirocumab (Praluent) – approved for it in the US
- Alteplase (Activase, Actilyse) – approved for it in the US, Switzerland, and France
- Amlodipine (Norliqva, Sdamlo, Amlodipine Besylate) – approved for it in the US and France
- Amlodipine and atorvastatin (Caduet) – approved for it in the US
- Atenolol (Tenormin, Tenormine, Atenolol Biogaran) – approved for it in the US and France
- Atorvastatin (Atorvaliq, Atorvastatin Calcium) – approved for it in the US
- Atorvastatin and ezetimibe (Ezetimibe/Atorvastatine Biogaran) – approved for it in France
- Bempedoic acid (Nexletol) – approved for it in the US
- Bempedoic acid and ezetimibe (Nexlizet) – approved for it in the US
- Betaxolol (Kerlone, Betaxolol Eg) – approved for it in France
- Bisoprolol (Detensiel, Bisoprolol Eg, Bisoprolol Teva) – approved for it in France
- Bivalirudin (bivalirudin) – approved for it in the US
- Captopril (captopril, Captopril Viatris, Captopril Eg) – approved for it in the US and France
- Celiprolol (Celectol) – approved for it in France
- Dalteparin (Fragmin) – approved for it in the US
- Diltiazem (Tiazac Extended Release, Tildiem, Bi Tildiem L.p.) – approved for it in the US and France
- Ezetimibe (Ezetrol, Ezetimibe Zydus) – approved for it in France
- Ezetimibe and simvastatin (Vytorin, Inegy, Ezetimibe/Simvastatine Biogaran) – approved for it in the US and France
- Felodipine (Flodil L.p., Felodipine Sandoz L.p.) – approved for it in France
- Fluindione (Previscan) – approved for it in France
- Fluvastatin (Fluvastatin Sodium Er, Lescol L.p.) – approved for it in the US and France
- Gemfibrozil – approved for it in the US
- Glyceryl trinitrate (Nitrolingual, Nitriderm Tts, Nitrostat) – approved for it in the US, Switzerland, and France
- Icosapent ethyl (Vascepa) – approved for it in the US
- Isosorbide dinitrate (Isoket, Isosorbide Dinitrate) – approved for it in the US and Switzerland
- Heparin (Heparine Calcique Panpharma, Heparine Sodique Panpharma, Calciparine Sous Cutanee) – approved for it in France
- Isosorbide mononitrate (isosorbide mononitrate) – approved for it in the US
- Lisinopril (Qbrelis, Zestril, Lisinopril Eg) – approved for it in the US and France
- Lovastatin – approved for it in the US
- Metoprolol (Toprol Xl, Lopressor, Seloken) – approved for it in the US and France
- Molsidomine (Corvaton, Corvasal, Molsidomine Biogaran) – approved for it in Switzerland and France
- Nadolol (Nadolol, Corgard) – approved for it in the US and France
- Niacin – approved for it in the US
- Nicardipine (Nicardipine Hydrochloride) – approved for it in the US
- Nicorandil (Nicorandil Rivopharm, Nicorandil Zentiva) – approved for it in Switzerland and France
- Nifedipine (Procardia XL, Nifedipine Arrow L.p., Nifedipine Viatris L.p.) – approved for it in the US and France
- Perindopril (Perindopril Biogaran, Perindopril Erbumine, Perindopril Arrow) – approved for it in the US and France
- Nadroparin (Fraxiparine) – approved for it in France
- Perindopril and amlodipine (Perindopril Amlo Spirig HC, Perindopril-Amlodipin-Mepha Teva) – approved for it in Switzerland
- Pindolol (Visken Quinze) – approved for it in France
- Pravastatin (Pravastatin sodium, Pravastatine Eg) – approved for it in the US and France
- Propranolol (Propranolol Teva, Propranolol Eg) – approved for it in France
- Ramipril (Ramipril, Triatec, Ramipril Sandoz) – approved for it in the US and France
- Rosuvastatin and ezetimibe (Zenon, Quiloga) – approved for it in Switzerland and France
- Simvastatin (Zocor) – approved for it in the US
- Ticlopidine (Ticlopidine Eg) – approved for it in France
- Timolol (Timolol Maleate, Timacor) – approved for it in the US and France
- Tirofiban (Aggrastat, Agrastat, Tirofiban Medac) – approved for it in the US and France
- Trandolapril (Trandolapril, Odrik, Trandolapril Biogaran) – approved for it in the US and France
- Trimetazidine (Vastarel) – approved for it in France
- Verapamil (Isoptine L.p., Verapamil Eg L.p.) – approved for it in France
- Warfarin (Warfarin Sodium) – approved for it in the US
- Zofenopril (Zofenil) – approved for it in France
Being tested in people
26 open trials in Austria, 1030 worldwide. See the trials
- 1-month DAPT (Phase 3)
- 12-month DAPT (Standard of care) (Phase 3)
- Acetyl Salicylic Acid (ASA) (Phase 3)
- acetylsalicylic acid (Phase 3)
Only in the lab or in animals
Not counted yet for this disease.
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Dichloroacetate (DCA) (only single reports in people)
- Hyperthermia (only single reports in people)
- Ketogenic diet (only single reports in people)
- Mistletoe extract (only single reports in people)
- Ivermectin (animal studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
1 open trial in Austria with these filters
Tracks safety and effectiveness of Medtronic products on the market
NCT01524276 · ClinicalTrials.gov
- Innsbruck – hospital not given
- Linz – hospital not given
No age limit given in the registry
Contact the trial team
Available abroad (96 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Implementing the 6th Generation Cardiac Troponin T
NCT07936630 · ClinicalTrials.gov
Countries: Denmark, Norway
- Herlev, Denmark – Copenhagen University Hospital - Herlev and Gentofte Hospital
- Horsens, Denmark – Regionshospitalet Horsens
- København NV, Denmark – Copenhagen University Hospital - Bispebjerg
No age limit given in the registry
Contact the trial teamCT Heart Imaging Tests for People With Stable Chest Pain
NCT04709900 · ClinicalTrials.gov
Countries: Denmark
- Copenhagen, Denmark – Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen
No age limit given in the registry
Contact the trial teamHeart scan to assess heart risk before kidney transplant
NCT06234410 · ClinicalTrials.gov
Countries: United Kingdom
- Edinburgh, United Kingdom – Royal Infirmary of Edinburgh
- Glasgow, United Kingdom – Queen Elizabeth Hospital
- London, United Kingdom – Imperial College Healthcare NHS Trust
Age 16 and over
Contact the trial teamObservational Registry Following Heart Conditions Through Routine Cardiac Testing
NCT04976348 · ClinicalTrials.gov
Countries: Netherlands
- Maastricht, Netherlands – Maastricht UMC
Age 16 and over
Contact the trial teamHeart and blood vessel risk in people with Crohn's disease and ulcerative colitis
NCT07095634 · ClinicalTrials.gov
Countries: Italy
- San Donato Milanese, Italy – IRCCS San Donato POliclinic
Age 16 and over
Contact the trial teamTests a computer-based method for diagnosing a rare heart artery condition
NCT06705751 · ClinicalTrials.gov
Countries: Italy
- San Donato Milanese, Italy – IRCCS Policlinico San Donato
Age 6 and over
Contact the trial teamUsing a blood marker to judge heart risks after bypass surgery in heart failure
NCT07480915 · ClinicalTrials.gov
Countries: Russia
- Tomsk, Russia – Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
No age limit given in the registry
Contact the trial teamRegistry recording heart artery disease and heart attacks at Barts Heart Centre
NCT05255705 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Barts Health NHS Trust
Age 16 and over
Contact the trial teamTracks heart complications in people receiving a donor stem cell transplant
NCT07157670 · ClinicalTrials.gov
Countries: France
- Paris, France – Saint Louis Hospital
Age 15 and over
Contact the trial teamChecks heart and blood vessel safety of tezepelumab in people with severe asthma
NCT06951867 · ClinicalTrials.gov
Countries: Germany, Denmark, France and 1 more
- Berlin, Germany – Team Gesundheit GKV Claims data (SHI)
- Copenhagen, Denmark – Danish registries (access/analysis)
- Paris, France – French National Health Data System (SNDS)
Ages 12 to 130
Contact the trial teamCounting Takotsubo Heart Cases and Their Outcomes in Scotland
NCT03299569 · ClinicalTrials.gov
Countries: United Kingdom
- Aberdeen, United Kingdom – Cardiac Research Office
No age limit given in the registry
Contact the trial teamStudies hormones and inflammation in women with coronary artery disease
NCT06327984 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Barts Health NHS Trust
Age 16 and over
Contact the trial teamRegistry Tracking Procedures to Open Fully Blocked Heart Arteries
NCT02061436 · ClinicalTrials.gov
Countries: Greece, Russia, Canada and 3 more
- Athens, Greece – Henry Hunant Hospital Center
- Athens, Greece – Korgialeneio-Benakeio Hellenic Red Cross General Hospital of Athens
- Novosibirsk, Russia – Meshalkin Novosibirsk Research Institute
No age limit given in the registry
Contact the trial teamShorter blood-thinner course after heart attack with ST-elevation
NCT05491200 · ClinicalTrials.gov
Countries: Belgium, Czechia, Germany and 3 more
- Bonheiden, Belgium – Imelda Bonheiden
- Bruges, Belgium – AZ St.Jan
- Genk, Belgium – ZOL Genk
No age limit given in the registry
Contact the trial teamUsing a wire-free blood flow measure to guide stenting in heart attack patients
NCT07598565 · ClinicalTrials.gov
Countries: Italy
- Roma, Italy – Azienda Ospedaliero-Universitaria Sant'Andrea
No age limit given in the registry
Contact the trial teamStudies coronary artery disease using heart scans and intracoronary imaging
NCT07565805 · ClinicalTrials.gov
Countries: Switzerland
- Bern, Switzerland – Department of Cardiology, Bern University Hospital Inselspital
No age limit given in the registry
Contact the trial teamTests regadenoson safety in children with heart artery disease
NCT04604782 · ClinicalTrials.gov
Countries: France, United Kingdom, Greece and 1 more
- Paris, France – Paris Public Hospitals System; Necker Hospital for Sick Children
- Bristol, United Kingdom – Bristol Royal Hospital for Children
- London, United Kingdom – King's College London, Rayne Institute
Ages 0 to 18
Contact the trial teamTracks heart attack patients discharged early from hospital after treatment
NCT06040528 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Barts Health NHS Trust
- London, United Kingdom – Dr. Daniel Jones
Age 16 and over
Contact the trial teamSingle Versus Dual Antiplatelet Medicine After Heart Stent Balloon Treatment
NCT06535568 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – IRCCS Auxologico Milano
No age limit given in the registry
Contact the trial teamHelping doctors and pharmacists use antibiotics more wisely for respiratory infections
NCT07359287 · ClinicalTrials.gov
Countries: France
- Caen, France – Chu Caen Normandie
No age limit given in the registry
Contact the trial teamFollows people with kidney disease and heart problems over time
NCT06521801 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Barts Health NHS Trust
Age 16 and over
Contact the trial teamFollowing heart attack patients whose coronary arteries are not blocked
NCT04440761 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Barts Health NHS Trust
Age 16 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTracks heart patients in a Swiss rehabilitation program over time
NCT05500859 · ClinicalTrials.gov
Countries: Switzerland
- Basel, Switzerland – University Hospital Basel, Division of Outpatient Cardiology
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamHeart muscle changes over time after a serious heart attack treated with stenting
NCT07041840 · ClinicalTrials.gov
Countries: Italy
- Pisa, Italy – University of Pisa, Cisanello Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamEye Scans to Study Small Blood Vessels in Heart Attacks With Normal Arteries
NCT07055152 · ClinicalTrials.gov
Countries: Italy
- Pisa, Italy – University of Pisa, Cisanello Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTool to help people with heart artery disease weigh stents or surgery
NCT06567626 · ClinicalTrials.gov
Countries: United Kingdom
- Leicester, United Kingdom – University Hospitals of Leicester
- Leicester, United Kingdom – University of Leicester
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamRegistry Following Adults With Heart Ischemia Without Blocked Arteries
NCT06588244 · ClinicalTrials.gov
Countries: Italy
- Naples, Italy – DPT of Advanced Biomedical Sciences
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies whether common heart medicines work equally well across different ethnic groups
NCT03987633 · ClinicalTrials.gov
Countries: United Kingdom
- Wolverhampton, United Kingdom – Future Genetics, The Science Centre, Wolverhampton Science Park
Age 6 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamCT heart scan versus invasive angiography in non-ST elevation acute coronary syndrome
NCT06101862 · ClinicalTrials.gov
Countries: Denmark
- Bispebjerg, Denmark – Bispebjerg Hospital
- Copenhagen, Denmark – Herlev and Gentofte Hospital
- Copenhagen, Denmark – Rigshospitalet
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamChecks Heart Artery Plaque Without Invasive Procedures Using a Deep Learning Tool
NCT06186336 · ClinicalTrials.gov
Countries: Italy
- Pavia, Italy – Ospedale Di Voghera, Azienda Socio-Sanitaria Territoriale di Pavia
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamEssen Registry Follows Patients Having Heart Artery Imaging
NCT04196712 · ClinicalTrials.gov
Countries: Germany
- Essen, Germany – University Hospital Essen
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamRegistry follows people with coronary artery disease and microvascular dysfunction
NCT02180178 · ClinicalTrials.gov
Countries: Germany
- Mainz, Germany – University Medical Center Mainz - 2 Medizinische Klinik
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamChecking coronary artery disease in donor hearts before transplant
NCT06528834 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Royal Brompton and Harefield Hospital NHS Trust
Ages 16 to 80
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamRegistry following heart patients after stent procedures in the Netherlands
NCT06512493 · ClinicalTrials.gov
Countries: Netherlands
- Heerlen, Netherlands – ZuyderlandMC
- Maastricht, Netherlands – MaastrichtUMC+
- Nijmegen, Netherlands – Radboud university medical centre
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamObservational study of heart attacks with non-blocked coronary arteries in Italy
NCT06511817 · ClinicalTrials.gov
Countries: Italy
- Roma, Italy – Fondazione Policlinico Universitario A. Gemelli IRCCS
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamRegistry Collecting Data on Coronary Vasomotor Function Testing in Patients
NCT06083155 · ClinicalTrials.gov
Countries: Netherlands
- Amsterdam, Netherlands – Amsterdam UMC
- Amsterdam, Netherlands – Onze Lieve Vrouwe Gasthuis (OLVG)
- Arnhem, Netherlands – Rijnstate Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamObserving patients with serious heart conditions in a cardiac intensive care unit
NCT06081205 · ClinicalTrials.gov
Countries: Greece
- Ioannina, Greece – University Hospital of Ioannina
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting feedback of treatment data to heart attack care teams
NCT00794001 · ClinicalTrials.gov
Countries: Germany
- Hildesheim, Germany – St.Bernward Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies a screening method for familial high cholesterol in people taking part in screening
NCT04929457 · ClinicalTrials.gov
Countries: Sweden
- Stockholm, Sweden – Karolinska University Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFollows people with coronary artery disease treated with heart stent procedures
NCT04185285 · ClinicalTrials.gov
Countries: Switzerland
- Fribourg, Switzerland – Cardiology, university Fribourg Medical Center
Ages 17 to 120
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Showing 40 of 96. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- In peoplePolarimetric Characterization of CCTA-Defined High-Risk Coronary Plaques: Linking Morphology to Fibrous Matrix Organization and Lipid Burden.Circ Cardiovasc Imaging · 2026-11-17
- ReviewCoronary Artery Bypass Graft versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis of 29,554 Patients.J Chest Surg · 2026-11-17
- Saponarin: a shield against coronary heart disease-related myocardial injury via NF-κB pathway inhibition.Front Cardiovasc Med · 2026-11-02
- ReviewDiagnostic Performance and Clinical Outcomes of Coronary Computed Tomography Angiography Before Valve Surgery: A Systematic Review and Meta-analysis.CJC Open · 2026-08-13
- Association and limited incremental discrimination of the systemic coagulation-inflammation index for Gensini-defined coronary anatomical burden.Front Cardiovasc Med · 2026-11-02
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichischer Herzverband
Nationwide association for people with heart disease: guides, information on heart conditions, self-help groups and membership; regional branches.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- European Heart Network
Alliance of national heart foundations and associations (some representing patients); EU-level prevention policy and patient interest advocacy. Mixed, not purely patient-led.
- Global Heart Hub
Global umbrella of heart patient organisations; runs a Heart Failure Patient Network, awareness campaigns, advocacy and patient resources.
- World Heart Federation
Global cardiovascular federation (mixed: heart foundations, medical societies and advocacy groups, not purely patient-led); campaigns, policy and World Heart Day.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.